Thrivent Financial for Lutherans’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,452
Closed -$235K 2546
2025
Q4
$235K Hold
12,452
﹤0.01% 2485
2025
Q3
$181K Sell
12,452
-38,218
-75% -$545K ﹤0.01% 2331
2025
Q2
$990K Sell
50,670
-7,269
-13% -$129K ﹤0.01% 1784
2025
Q1
$1.03M Hold
57,939
﹤0.01% 1690
2024
Q4
$1.24M Sell
57,939
-23,392
-29% -$569K ﹤0.01% 1769
2024
Q3
$2.54M Hold
81,331
﹤0.01% 1280
2024
Q2
$1.26M Sell
81,331
-3,473
-4% -$42K ﹤0.01% 1713
2024
Q1
$898K Hold
84,804
﹤0.01% 1951
2023
Q4
$1.02M Buy
+84,804
New +$695K ﹤0.01% 1831

Other funds holding CDNA

Thrivent Financial for Lutherans's CDNA Position: Q1 2026 in Review

Thrivent Financial for Lutherans sold out of CareDx (CDNA) in Q1 2026, closing a stake of 12,452 shares — an estimated $235K sold.

Thrivent Financial for Lutherans first reported a position in CDNA in Q4 2023 and held it in 9 quarters. The position peaked at $2.54M in Q3 2024. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Thrivent Financial for Lutherans reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 12,452 CareDx shares in Q1 2026, an estimated $235K.
  • Thrivent Financial for Lutherans first reported a position in CareDx in Q4 2023 and held it in 9 quarters.
  • Thrivent Financial for Lutherans's CareDx position peaked at $2.54M in Q3 2024.
  • 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.